Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers

In the 115 years since the discovery of Alzheimer’s disease (AD), our knowledge, diagnosis, and therapeutics have significantly improved. Biomarkers are the primary tools for clinical research, diagnostics, and therapeutic monitoring in clinical trials. They provide much insightful information, and...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Sakulrat Mankhong, Sujin Kim, Seongju Lee, Hyo-Bum Kwak, Dong-Ho Park, Kyung-Lim Joa, Ju-Hee Kang
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI AG 2022-04-01
Serie:Biomedicines
Ämnen:
Alzheimer’s biomarker
cerebrospinal fluid
blood-based biomarker
clinical trial
amyloid-beta
tau
Länkar:https://www.mdpi.com/2227-9059/10/4/850
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk